Cumberland Pharmaceuticals Launches New Sancuso® Website Featuring Educational Resources for Chemotherapy-Induced Nausea and Vomiting Life Science Investing
Galectin Therapeutics Strengthens Board of Directors with Appointment of Henry Brem, M.D. Life Science Investing
Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer Pharmaceutical Investing
CytomX Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants Life Science Investing
CytomX Therapeutics Announces 2025 Financial Results and Provides Business Update Life Science Investing
NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Givastomig in Gastric Cancer Life Science Investing
CytomX's Varsetatug Masetecan Continues to Demonstrate Positive Data Supporting Potential as a New Treatment Option in Late-Line Colorectal Cancer Life Science Investing
New York Plastic Surgical Group and Deep Blue Med Spa Named #1 in New York by Allergan Aesthetics for the Second Year in a Row Pharmaceutical Investing
BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026 Pharmaceutical Investing
Nektar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results Life Science Investing
